Brief: Coherus To Collaborate With The Cancer Research Institute
08/05/2024 14:19
May 8 (Reuters) - Coherus BioSciences Inc CHRS.O :
* COHERUS ANNOUNCES CLINICAL COLLABORATION WITH THE CANCER
RESEARCH INSTITUTE FOR A NOVEL COMBINATION EVALUATING LOQTORZI®
(TORIPALIMAB-TPZI) WITH ENB THERAPEUTICS' ENB-003 FOR THE
TREATMENT OF OVARIAN CANCER
Source text for Eikon: ID:nGNX5TkKCy
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million